Inventor

Barry Peter Clark

Inventor
Lower Froyle, GB

Overview

24→
Patents
1981–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations42%
C07DHeterocyclic compounds40%
C07CAcyclic or carbocyclic compounds8%
A61KPreparations for medical, dental or toiletry purposes4%
C07BGeneral methods of organic chemistry2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments2%
PatentTitleYear
11,091,864Methods and systems for making a sewn product using a robot20218,575,214'MGlu 2/3 agonists'20138,202,873'2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists'20127,619,096'3-Aminopyrrolidines as inhibitors of monoamine uptake'20097,615,648'Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake'20097,521,462'4-Amino-piperidine derivatives as monoamine uptake inhibitors'20097,488,728'Pyridinylmorpholine derivatives'20097,432,280'3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake'20087,384,941'2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors'20087,294,623'Benzyl morpholine derivatives'20076,482,824'Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists'20026,054,448'2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives'20005,891,899'Pharmaceutical xanthene compounds'19995,863,947'Phenylglycine derivatives useful for treating disorders of the central nervous system'19995,580,900'Macrocyclic compounds'19965,574,158'Compounds'19965,428,065'1,3-benzenedimethanamines useful as central nervous system active agents'19955,258,378'Pyrroloazepine compounds useful as dopaminergic agents'19935,028,602'Pharmaceutical compounds'19914,904,653'Thieno[2,3-O]azepine compounds and CNS affecting use thereof'19904,471,129'6-Substituted pyranone compounds and their use as pharmaceuticals'19844,448,787'6-Substituted pyranone compounds and their use as pharmaceuticals'19844,364,956'5-Substituted pyranone compounds and their use as pharmaceuticals to treat an immediate hypersensitivity condition'19824,304,728'6-Substituted pyranone compounds and their use as pharmaceuticals'1981

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1981–1996Patents assigned to LILLY INDUSTRIES LTD (10)· patent assignee history
1981–1984Based in Fleet, GB· patent location history
1990–2013Based in Lower Froyle, GB· patent location history
1999–2013Patents assigned to LILLY CO ELI (13)· patent assignee history
2002Based in Hampshire, GB· patent location history
2007–2012Based in Basingstoke, GB· patent location history
2012Patents assigned to BADESCU VALENTINA O (1)· patent assignee history
2012Patents assigned to CAMP ANNE MARIE (1)· patent assignee history
2012Patents assigned to CLARK BARRY PETER (1)· patent assignee history
2021Based in Seattle, WA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LILLY CO ELI131999–2013
LILLY INDUSTRIES LTD101981–1996
BADESCU VALENTINA O12012
CAMP ANNE MARIE12012
CLARK BARRY PETERself12012
Locations
LocationPatentsSpan
Lower Froyle, GB91990–2013
Basingstoke, GB82007–2012
Fleet, GB41981–1984
Seattle, Washington, US12021
Hampshire, GB12002